Minimal Risk Studies and Expedited Review

Ended: May 2, 2017

Sponsored by the MGH Clinical Research Program and Partners Human Research Committee

What Constitutes a Minimal Risk Study?

Specific categories of human subject research can be approved via the expedited review procedure if it presents no more than minimal risk to subjects. IRB Chair, Melissa Frumin, MD, will offer insight into what qualifies as minimal risk, the categories of research that are eligible for expedited review and the ethical issues surrounding minimal risk studies.

This course is designed for Clinical Research Coordinators, Research Nurses and Project Managers, though all are welcome to attend. Please feel free to bring your lunch.

Registration is required. Please contact dcredu@partners.org with any questions.




Sponsor:
MGH Division of Clinical Research

Sessions

May 2, 2017 05/2/17
11AM-12PM
11 AM – 12 PM
Garrod/Mendel, Floor 2, Simches Research Center